Cencora, Inc.COR

NYSEHealthcareWholesale-Drugs, Proprietaries & Druggists' Sundries
Price (close)
$306.92
Market cap
$58.6B
P/E
22.3x
Revenue (TTM)
$332.8B
Net income
$2.6B
Dividend yield
0.78%
1-year total return
3.5%
Net margin
0.8%
Revenue growth
5.1%
Debt / equity
3.84x

What Cencora, Inc. does.

Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. More specifically, we distribute a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers located in the United States and select global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, physician practices, medical and dialysis clinics, veterinarians, and other customers. Additionally, we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related services, including data analytics, outcomes research, reimbursement and pharmaceutical consulting services (including regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance) niche premium logistics services, inventory management, pharmacy automation, pharmacy management, and packaging solutions.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$189.9B$214.0B$238.6B$262.2B$294.0B$321.3B
Net income-$3.4B$1.5B$1.7B$1.7B$1.5B$1.6B
Free cash flow$1.8B$2.2B$2.2B$3.5B$3.0B$3.2B

More on COR.

Figures from Cencora, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.